APA (7th ed.) Citation

ML, S., A, A., B, N., C, B., P, B., V, B., . . . R, F. (2022). Effectiveness of ustekinumab in patients with refractory Crohn's disease: A multicentre real-life study in Italy. Therapeutic advances in gastroenterology, 15, 17562848211072412. https://doi.org/10.1177/17562848211072412

Chicago Style (17th ed.) Citation

ML, Scribano, et al. "Effectiveness of Ustekinumab in Patients with Refractory Crohn's Disease: A Multicentre Real-life Study in Italy." Therapeutic Advances in Gastroenterology 15 (2022): 17562848211072412. https://doi.org/10.1177/17562848211072412.

MLA (9th ed.) Citation

ML, Scribano, et al. "Effectiveness of Ustekinumab in Patients with Refractory Crohn's Disease: A Multicentre Real-life Study in Italy." Therapeutic Advances in Gastroenterology, vol. 15, 2022, p. 17562848211072412, https://doi.org/10.1177/17562848211072412.

Warning: These citations may not always be 100% accurate.